Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NDUFV2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LTBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTBN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00334 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0E2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01198 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHEK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on